Skip to main content
. 2017 Dec 22;3(2):e000573. doi: 10.1136/rmdopen-2017-000573

Figure 3.

Figure 3

Outcome according to final clinical diagnosis. DMARD, disease-modifying antirheumatic drug; PsA, psoriatic arthritis; RA, rheumatoid arthritis; ReA, reactive arthritis; SpA, spondyloarthritis; UA, undifferentiated arthritis.